Active ingredientMedroxyprogesterone AcetateCat. No. P-M029-001CAS 71-58-9Family · Pharmaceutical analytical standards
Medroxyprogesterone
A synthetic progestin discovered in 1956 and in use since 1959, used as medroxyprogesterone acetate for menstrual disorders, menopausal hormone therapy, contraception and some hormone-dependent tumours. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?It was developed partly because for decades natural progesterone could not be taken by mouth. In its injectable 'depot' form, used as a contraceptive since 1969, a single injection lasts about three months.
Go to the active ingredient →Active ingredientMedroxyprogesterone AcetateCat. No. P-M029-001CAS 71-58-9
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity ACat. No. P-M029-002CAS 984-47-4
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity BCat. No. P-M029-003CAS 520-85-4
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity CCat. No. P-M029-004
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity DCat. No. P-M029-005CAS 2242-65-1
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity ECat. No. P-M029-006CAS 32634-95-0
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity FCat. No. P-M029-007CAS 69688-15-9
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity ICat. No. P-M029-008CAS 3112446-15-5
MetaboliteMedroxyprogesterone GlucuronideCat. No. P-M029-009
Isotopically labelledMedroxyprogesterone 17-Acetate-d3Cat. No. P-M029-010CAS 162462-70-6
Isotopically labelledMedroxyprogesterone 17-Acetate-d6Cat. No. P-M029-011
Isotopically labelledMedroxyprogesterone Acetate EP Impurity B-d3Cat. No. P-M029-012CAS 162462-69-3
Isotopically labelledMedroxyprogesterone acetate-13C2-d3Cat. No. P-M029-013
Isotopically labelledMedroxyprogesterone acetate-d10Cat. No. P-M029-014
Isotopically labelledMedroxyprogesterone-13C-d3Cat. No. P-M029-015
Isotopically labelledMedroxyprogesterone-d7Cat. No. P-M029-016
Impurity1,2-Dehydro MedroxyprogesteroneCat. No. P-M029-017CAS 3660-13-7
Impurity16alpha,17alpha-EpoxyprogesteroneCat. No. P-M029-018CAS 1097-51-4
Impurity2-beta, 6-beta-Dihydroxy-Medroxyprogesterone AcetateCat. No. P-M029-019
Impurity2beta-Hydroxy Medroxyprogesterone 17-Acetate (>90%)Cat. No. P-M029-020CAS 1072923-64-8
ImpurityMedroxyprogesterone Impurity 1Cat. No. P-M029-021CAS 16319-93-0
ImpurityMedroxyprogesterone Impurity 2Cat. No. P-M029-022CAS 984-46-3
ImpurityMedroxyprogesterone Impurity 3Cat. No. P-M029-023CAS 113891-99-9
ImpurityMedroxyprogesterone Impurity 4Cat. No. P-M029-024CAS 1072923-65-9
ImpurityMedroxyprogesterone Impurity 5Cat. No. P-M029-025CAS 28018-91-9
ImpurityMedroxyprogesterone Impurity 6Cat. No. P-M029-026CAS 2128317-86-0
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity GCat. No. P-M029-027CAS 595-33-5
Pharmacopoeial impurityMedroxyprogesterone Acetate EP Impurity HCat. No. P-M029-028CAS 302-23-8No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceMedroxyprogesterone acetate CRSEDQM code M0250000Family MedroxyprogesteroneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.